Sinonasal (Schneiderian) Tumors in the Temporal Bone: Case Series and Systematic Review

References

1. 1.↵
   2. Bishop JA

   . OSPs and ESPs and ISPs, Oh my! An update on sinonasal (Schneiderian) papillomas. Head Neck Pathol 2017;11:269–77 doi:10.1007/s12105-017-0799-9 pmid:28321771

   CrossRefPubMed
2. 2.↵
   2. El-Naggar A,
   3. Chan J,
   4. Grandis J

   , et al., eds. WHO Classification of Head and Neck Tumours. Vol 9. 4th ed. World Health Organization; 2017
3. 3.↵
   International Agency for Research on Cancer. WHO Classification of Tumours online. 2022 https://tumourclassification.iarc.who.int. Accessed November 13, 2023
4. 4.↵
   2. Chin SC,
   3. Fatterpekar G,
   4. Chen CY, et al

   . MR imaging of diverse manifestations of nasopharyngeal carcinomas. AJR Am J Roentgenol 2003;180:1715–22 doi:10.2214/ajr.180.6.1801715 pmid:12760949

   CrossRefPubMed
5. 5.↵
   2. Yang MS,
   3. Chen CC,
   4. Cheng YY, et al

   . Nasopharyngeal carcinoma spreading along the eustachian tube: the imaging appearance. J Chin Med Assoc 2004;67:200–03 pmid:15244021

   PubMed
6. 6.↵
   2. Lai JW,
   3. Cheng AC,
   4. Tong M, et al

   . Sneaking its way up: external auditory canal involvement by an otherwise inconspicuous nasopharyngeal carcinoma via spread through the eustachian tube. Hong Kong J Radiol 2015;18:e1–e6 doi:10.12809/hkjr1414253

   CrossRef
7. 7.↵
   2. Lin HW,
   3. Richmon JD,
   4. Emerick KS, et al

   . Malignant transformation of a highly aggressive human papillomavirus type 11-associated recurrent respiratory papillomatosis. Am J Otolaryngol 2010;31:291–96 doi:10.1016/j.amjoto.2009.02.019 pmid:20015762

   CrossRefPubMed
8. 8.↵
   Centre for Evidence-Based Medicine. Oxford Centre for Evidence-Based Medicine: Levels of Evidence (March 2009). https://www.cebm.ox.ac.uk/resources/levels-of-evidence/oxford-centre-for-evidence-based-medicine-levels-of-evidence-march-2009. Accessed May 5, 2023
9. 9.↵
   2. Kawaguchi M,
   3. Kato H,
   4. Tomita H, et al

   . Imaging characteristics of malignant sinonasal tumors. J Clin Med 2017;6:116 doi:10.3390/jcm6120116 pmid:29211048

   CrossRefPubMed
10. 10.↵
    2. Brown NA,
    3. Plouffe KR,
    4. Yilmaz O, et al

    . TP53 mutations and CDKN2A mutations/deletions are highly recurrent molecular alterations in the malignant progression of sinonasal papillomas. Mod Pathol 2021;34:1133–42 doi:10.1038/s41379-020-00716-3 pmid:33203919

    CrossRefPubMed
11. 11.↵
    2. Redaelli de Zinis LO,
    3. Parrinello G,
    4. Schreiber A, et al

    . Middle ear effusion in patients with sinonasal cancer treated by surgery with or without radiotherapy. Otolaryngol Head Neck Surg 2013;148:619–24 doi:10.1177/0194599812474798 pmid:23348873

    CrossRefPubMed